Cargando…
Lower‐Intensity Statins Contributing to Gaps in Care for Patients With Primary Severe Hypercholesterolemia
BACKGROUND: Although severe hypercholesterolemia confers a 5‐fold increased long‐term risk for coronary artery disease, treatment guidelines may not be fully implemented, leading to underdiagnosis and suboptimal treatment. To further understand the clinical features and gaps in treatment approaches,...
Autores principales: | Eid, Wael E., Sapp, Emma Hatfield, Flerlage, Elijah, Nolan, Joseph R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649304/ https://www.ncbi.nlm.nih.gov/pubmed/34465130 http://dx.doi.org/10.1161/JAHA.121.020800 |
Ejemplares similares
-
MON-LB309 Prevalence and Characteristics of Patients With Primary Severe Hypercholesterolemia in a Multidisciplinary Healthcare System in the Midwest
por: Eid, Wael Emad, et al.
Publicado: (2020) -
Improving Familial Hypercholesterolemia Diagnosis Using an EMR-based Hybrid Diagnostic Model
por: Eid, Wael E, et al.
Publicado: (2021) -
Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
por: Vuorio, Alpo, et al.
Publicado: (2021) -
Familial hypercholesterolemia class II low-density lipoprotein receptor response to statin treatment
por: Omer, Linda, et al.
Publicado: (2020) -
Vulnerable plaque derived from aspirated thrombi in recurrent acute coronary syndrome with familial hypercholesterolemia despite intensive lipid-lowering statin therapy
por: Natsui, Hiroyuki, et al.
Publicado: (2022)